Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
InspireSemi and E4 Computer Engineering Collaboration and Exhibiting at RISC-V Europe Summit 2026
-
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
-
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
-
Bread Financial to Participate in the Morgan Stanley US Financials Conference
-
Mowi ASA (OSE:MOWI): Annual General Meeting held
-
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
-
Premier Development & Investment, Inc. to Amend Articles in Order to Capitalize and Eliminate Certain Long Term Liabilities and All Short Term Loans Totaling no Less Than $29 Million
-
Premier Development & Investment, Inc. to Amend Articles in Order to Capitalize and Eliminate Certain Long Term Liabilities and All Short Term Loans Totaling no Less Than $29 Million
-
Application for Admission of Shares
-
GigaCloud Technology Inc Named to TIME’s ‘World’s Growth Leaders 2026’ List
-
Destination XL Group Provides Update on Pending Merger with FullBeauty Brands
-
Mammogen Secures Up to $30 Million Series A Financing Backed by Leading U.S. Public Retirement System to Advance Blood-Based RNA Breast Cancer Detection Platform
-
The Infrastructure Behind the Exchange: ViaBTC Group’s Decade-Long Journey with CoinEx
-
IREN Announces First Australian Data Center Campus - 800MW in South Australia
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
Highland Copper Identifies Key Optimization Opportunities Through Detailed Engineering at the Copperwood Project
-
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Sym
-
Joveo Introduces AI Talent Campaigns to Help Recruiters Launch Multi-Touch Outreach in Minutes
-
Payments Canada welcomes new members as membership growth accelerates
-
Emerita Announces Appointments of New Independent Director and Corporate Secretary
-
Informativ Earns 2026 Great Place To Work Certification™ and Is Named to Fortune Best Workplaces in Texas™ List, Marking Three Consecutive Years of Verified Employee Satisfaction
-
DMW&H Achieves SOC 2® Compliance Milestone
-
Stop & Shop Declares June 3rd As First-Ever National Chicken Salad Day
-
AX Coin, Backed by AXG, Granted First Stablecoin Issuer License by the Central Bank of Bahrain
-
Blossom Gold Receives Approval from BLM Regarding Notice of Intent to Initiate Exploration Drilling on the Kamma Claims West of the Rosebud Project
-
Solana Unchained Showcases Real-World Token Utility as New Generation of AI Crypto Projects Emerges
-
Pennant Expands Senior Living Presence with Pleasant Hill, California Community
-
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
-
Destination XL Group, Inc. Reports First Quarter Financial Results
-
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
-
Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China
-
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Twisted Shotz Brings the Twist Back to the Shooter Category
-
FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
-
Reflexivity Brings Real-Time Portfolio Intelligence to Microsoft 365 Copilot
-
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
-
Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2026 Results
-
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
-
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
-
SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer
-
ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance, Announces Investor Day Details
-
Solera Launches In-State Pennsylvania Titling for Dealers and Tag Agencies
-
FactSet Schedules Third Quarter 2026 Earnings Call
-
DMW&H Achieves SOC 2® Compliance Milestone
-
OTC Markets Group Welcomes Atomic Eagle Ltd to OTCQX
-
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
-
79% of Enterprises Are Confident They Can Scale AI Without Breaking Governance. Only 29% Can Even Find the Data.
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy
